Significance of Apoptosis in Endometrial Hyperplasia Carcinoma

Significance of Apoptosis in Endometrial Hyperplasia Carcinoma

Saved in:

Bibliographic Details
Main Authors:	Vidyavathi K, Harendra Kumar M L, Narayanaswamy M
Format:	Article
Language:	English
Published:	Sri Devaraj Urs Academy of Higher Education and Research 2011-03-01
Series:	Journal of Clinical and Biomedical Sciences
Online Access:	https://jcbsonline.ac.in/articles/significance-of-apoptosis-in-endometrial-hyperplasia-carcinoma
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of cyclin D1 on endometrial hyperplasia and endometrioid endometrial carcinoma
by: Sudha M, et al.
Published: (2025-06-01)

Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study.
by: Clara M Prip, et al.
Published: (2022-01-01)

Hyperplasia and endometrial precancer
by: O. A. Gornikh, et al.
Published: (2014-08-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
by: An-Ju Chou, et al.
Published: (2024-11-01)

To the question of the pathogenesis of endometrial hyperplasia
by: A. Kh. Bishtavi, et al.
Published: (2014-07-01)

Role of steroid hormones, estrogen receptors and metabolites in the development of endometrial hyperplasia and carcinoma
by: A. L. Chernyshova, et al.
Published: (2012-12-01)

CELL MOTILITY PROTEINS IN ENDOMETRIUM CARCINOMA AND ENDOMETRIAL HYPERPLASIA: ASSOCIATION WITH CANCER RISK
by: N. V. Yunusova, et al.
Published: (2020-10-01)

HORMONAL AND ENERGETIC CHANGES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER
by: A. L. Chernyshova, et al.
Published: (2016-02-01)

Modern approaches to the diagnosis of endometrial hyperplasia
by: M. M. Damirov, et al.
Published: (2025-02-01)

Study of Immunohistochemical Expression Patterns of Mismatch Repair Proteins in Endometrial Carcinoma and Endometrial Hyperplasia: An Institutional Study
by: Belani Vaishali Tulsidas, et al.

ENDOMETRIAL POLYP WITH ENDOMETRIAL HYPERPLASIA &CHRONIC INFLAMMATION IN RABBITS
by: Asmaa Sh.Aliawy
Published: (2012-12-01)

MOLECULAR PROFILES OF ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
by: S. A. Levakov, et al.
Published: (2018-08-01)

Endometrial hyperplasia and endometrial polyps: clinical and anamnestic characteristics of women
by: E. N. Kravchenko, et al.
Published: (2024-01-01)

Diagnosis of endometrial hyperplasia in routine gynecological practice
by: Ye. M. Poliakova, et al.
Published: (2019-02-01)

Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014-07-01)

ENDOMETRIAL HYPERPLASIA: CONTROVERSIAL ISSUES OF PATHOGENESIS AND THERAPY
by: Yu. Yu. Tabakman, et al.
Published: (2016-10-01)

CEBPB promotes transformation of endometrial complex atypical hyperplasia to endometrial cancer
by: Jiahong Tan, et al.
Published: (2025-06-01)

Microsatellite instability as a reliable marker of coexisting endometrial cancer in atypical endometrial hyperplasia
by: А. E. Protasova, et al.
Published: (2024-07-01)

Proteasome activity and subunit composition in endometrial hyperplasia and cancer
by: L. V. Spirina, et al.
Published: (2014-08-01)

Predicting the risk of malignisation of endometrial hyperplasia in reproductive age
by: I. M. Ordiyants, et al.
Published: (2020-03-01)

Pregnancy outcomes of endometrial hyperplasia with or without atypia
by: Seon Ui Lee, et al.
Published: (2025-07-01)

THE RESULTS OF COMPUTER MORPHOMETRY USED IN ENDOMETRIAL HYPERPLASIA
by: Yu. Yu. Tabakman, et al.
Published: (2016-06-01)

Atypical endometrial hyperplasia in the conception of tumor progression (literature review)
by: M. M. Damirov, et al.
Published: (2025-06-01)

Tissue-Based Metabolomic Profiling of Endometrial Cancer and Hyperplasia
by: Khalid Akkour, et al.
Published: (2025-07-01)

Current approaches to the treatment of endometrial hyperplasia in women with uterine leiomyoma
by: Potapov V.A., et al.
Published: (2014-09-01)

Immunohistochemical features of cyclooxygenase-2 expression in endometrial hyperplasia without atypia
by: N. Ye. Horban, et al.
Published: (2019-07-01)

COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
by: A. I. Pashov, et al.
Published: (2012-05-01)

Diagnosis of Cystic Endometrial Hyperplasia and Hydrometra in a Pet Goat
by: Ryo Nishimura, et al.
Published: (2025-01-01)

Treatment of Chronic Endometritis with Vague Symptoms in Patients with Endometrial Hyperplasia
by: N. I. Volotskaya, et al.
Published: (2024-03-01)

Current approaches to diagnosing and preventing endometrial hyperplasia: A review
by: Irina V. Kuznetsova, et al.
Published: (2025-01-01)

Comparatively analyzed quality of life in patients with atypical endometrial hyperplasia and endometrial cancer during various rehabilitation activities
by: L. N. Sandzhieva, et al.
Published: (2022-09-01)

Expression and Prognostic Significance of Wnt7a in Human Endometrial Carcinoma
by: Chunjie Peng, et al.
Published: (2012-01-01)

The value of diffusion-weighted imaging and semi-quantitative dynamic contrast-enhanced MRI in predicting the efficacy of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial carcinoma
by: Mingming Liu, et al.
Published: (2025-07-01)

Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes
by: Xu S, et al.
Published: (2025-02-01)

ENDOMETRIAL CELLS APOPTOSIS IN HEALTH AND PROLIFERATIVE DISEASES OF THE UTERUS
by: N. V. Borovkova, et al.
Published: (2016-06-01)

Clinical Utility of Systemic Inflammation Markers in Identifying Endometrial Hyperplasia and Adenocarcinoma
by: Tevfik B. Bıldacı, et al.
Published: (2024-10-01)

The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer: a retrospective study
by: Yuanyuan Wang, et al.
Published: (2025-04-01)

RETRACTED: Expression and clinical significance of SERPINA3 and EFEMP2 in endometrial carcinoma
by: Shaoguang Wang, et al.
Published: (2018-06-01)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016-09-01)

Achievements and prospects of therapy for non-atypical endometrial hyperplasia in reproductive-aged women
by: D.A. Khaskhachikh
Published: (2024-12-01)